# Bioenvision

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioenvision

- Industry: Healthcare
- Headquarters: New York, US
- Total disclosed funding: $18M
- Latest round: Series A (May 20, 2002)
- Investors on record: 4

## About

Bioenvision, Inc. is based in US and engages in the development and commercialization of therapeutic treatments, primarily in oncology.

## Funding rounds

- Series A, May 20, 2002, $18M — OrbiMed Advisors, Aisling Capital, DWS Investments, Merlin BioMed Group

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A
- Aisling Capital (https://capitalatlas.ai/funds/aisling-capital) — Series A
- DWS Investments — Series A
- Merlin BioMed Group — Series A